Publications and Posters
Search our publications, posters, and presentations by title, author, journal, year, or keywords.
"Mistakes are understandable, failing to report them is inexcusable."Mark Maier and Eberhardt Rechtin, 1997
Good Reads
- Prediction of Efficacy for Conversion From Adjunctive Therapy to Monotherapy With Eslicarbazepine Acetate 800 mg Once Daily for Partial-onset Epilepsy
- Population Pharmacokinetic Modeling of Armodafinil and Its Major Metabolites
- Interactive Code for Guiding Dose Selection
- In Silico Prediction of Oral Bioavailability
- Pharmacokinetics and Exposure-Response Relationships of Dasotraline in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
- Toward Progressive Reporting of Modeling and Simulation Results - Part 1: Analysis of KIWI Metadata
- Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function
- Population Pharmacokinetic Evaluation of Eslicarbazepine Acetate for Adjunctive Therapy in…
- Impact of Delayed-Dose Administration of USL255, Qudexy™ XR (Topiramate) Extended-Release Capsules
- Tedizolid population pharmacokinetics, exposure-response, and target attainment
- Exposure-response analysis of eslicarbazepine acetate as adjunctive treatment of patients with partial-onset seizures
- The development of a population pharmacokinetic (PK) model for linezolid
- Engineering the Pharmacometrics Enterprise
- Exposure-response analyses of tigecycline tolerability in healthy subjects
- Improving the efficiency and ensuring the quality of data assembly for pharmacometric analysis
- Pharmacometrics and the transition to model-based development
- Informatics: the fuel for pharmacometric analysis
- A new paradigm of real-time data assembly to support knowledge-based decision making: a case study
- Integrating real-time data assembly (RTDA) and population pharmacokinetics as tactical components of cognitive engineering
